To test the effectiveness and safety of the drug ravulizumab in patients aged 6-18 years.
Thank you for your interest, but this study is recruiting by invitation only.
United States (Nationwide)
James Howard
Neurology-Neuromuscular
Clinical or Medical
Interventional
Bones, Joints, Muscles
Chronic Conditions
23-2163
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
